Larimar Therapeutics (LRMR) Return on Assets [ROA] (2014 - 2026)
Larimar Therapeutics (LRMR) recorded Return on Assets [ROA] of -112.91% in Q2 2026, down 45.11 percentage points from -67.80% a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Larimar Therapeutics reported Return on Assets [ROA] of -99.69%, down 38.31 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for three straight years, with a five-year change of -21.78 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -61.38% in FY2024 (-23.82 pp), -37.56% in FY2023 (-1.94 pp), -35.62% in FY2022 (+19.42 pp) and -55.05% in FY2021 (+22.86 pp).
- The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] in data going back to Q3 2014.
- On a year-over-year basis, Return on Assets [ROA] rose in 1 of the last seven quarters, with an average year-over-year change of -31.78 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 34.28 percentage points in Q1 2023, against a drop of 60.18 percentage points in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Larimar Therapeutics | 307.49 Mn | -299.58 Mn | - | -112.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -112.91% |
| Dec 31, 2025 | -103.54% |
| Sep 30, 2025 | -82.87% |
| Jun 30, 2025 | -67.80% |
| Mar 31, 2025 | -56.88% |
| Dec 31, 2024 | -43.36% |
| Sep 30, 2024 | -32.34% |
| Jun 30, 2024 | -27.13% |
| Mar 31, 2024 | -29.55% |
| Dec 31, 2023 | -41.78% |
| Sep 30, 2023 | -35.27% |
| Jun 30, 2023 | -31.40% |
| Mar 31, 2023 | -28.76% |
| Dec 31, 2022 | -28.16% |
| Sep 30, 2022 | -35.92% |
| Jun 30, 2022 | -64.72% |
| Mar 31, 2022 | -63.04% |
| Dec 31, 2021 | -60.58% |
| Sep 30, 2021 | -66.06% |
| Jun 30, 2021 | -56.77% |
API Access
Larimar Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();